Elevated procalcitonin as a diagnostic marker in meningococcal disease

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 25, Issue 8, 2006, Pages 501-509

  Mills, G D ^a   Lala, H M ^a   Oehley, M R ^a   Craig, A B ^b   Barratt, K ^c   Hood, D ^d   Thornley, C N ^f   Nesdale, A ^g   Manikkam, N E ^b   Reeve, P ^e  

^a WAIKATO HOSPITAL   (New Zealand)

^b Waikato District Health Board   (New Zealand)

^c Molecular Biology Department   (New Zealand)

^d Health Waikato   (New Zealand)

^e Waikato District Health Board   (New Zealand)

^f Auckland Regional Public Health Service   (New Zealand)

^g Regional Public Health   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; PROCALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; EMERGENCY WARD; EPIDEMIC; FEMALE; FEVER; GRAM STAINING; HUMAN; INFANT; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCEMIA; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NEW ZEALAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 33747356268     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-006-0179-y     Document Type: Article

References (32)

1. Herrick W (1919) Extrameningeal meningococcus infections. Arch Intern Med 23:409-418
2. Wells LC, Smith JC, Weston VC, Collier J, Rutter N (2001) The child with a non-blanching rash: how likely is meningococcal disease? Arch Dis Child 85:218-222
3. Wilks D, Lever AM (1996) Reasons for delay in administration of antibiotics to patients with meningitis and meningococcaemia. J Infect 32:49-51
4. Riordan FA, Thomson AP, Sills JA, Hart CA (1996) Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ 313:1255-1256
5. Nadel S, Britlo J, Boey R, Maconochie I, Habibi P, Levin M (1998) Avoidable deficiencies in the delivery of health care to children with meningococcal disease. J Accid Emerg Med 15:298-303
6. Dashefsky B, Teele D, Klein J (1983) Unsuspected meningococcemia. J Pediatr 102:69-72
7. Martin D, McDowell R, Sneyd E, Baker M (2004) The epidemiology of meningococcal disease in New Zealand in 2003. New Zealand Ministry of Health, Institute of Environmental Science and Research, Wellington, pp 1-32
8. Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guerin S, Ravilly S, Lefevre H, Royer C, Lacombe C, Palmer P, Bohuon C (1999) Comparison of procalcitonin with C-reactive protein, interleukin-6 and interferon-alpha for differentiation of bacterial vs viral infections. Pediatr Infect Dis J 18:875-881
9. Van Rossum AMC, Wulkan RW, Oudesluys-Murphy AM (2004) Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 4:620-630
10. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206-217
11. Carrol ED, Thomson AP, Hart CA (2002) Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20:1-9
12. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605-1608
13. Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, Reinhart K (1999) Sensitivity and specificity of various markers of inflammation for the prediction of tumour necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 27:1814-1818
14. Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, Bertran JC (1999) High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 28:1313-1316
15. Bugden SA, Coles C, Mills GD (2004) The potential role of procalcitonin in the emergency department management of febrile young adults during a sustained meningococcal epidemic. Emerg Med Austral 16:114-119
16. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, Kaczmarski EB (2001) Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39:1553-1558
17. Meisner M (2000) Procalcitonin. A new, innovative infection parameter. Biochemical and clinical aspects. Thieme, Stuttgart, p 180
18. Derkx HH, van den Hoek J, Redekop WK, Bijlmer RP, van Deventer SJ, Bossuyt PM (1996) Meningococcal disease: a comparison of eight severity scores in 125 children. Intensive Care Med 22:1433-1441
19. Lopez AF, Cubells CL, Garcia JJG, Pou JF (2003) Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicentre study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J 22:895-903
20. Carrol ED, Newland P, Riordan FA, Thomson AP, Curtis N, Hart CA (2002) Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child 86:282-285
21. Van der Kaay DC, de Kleijn ED, de Rijke YB, Hop WC, de Groot R, Hazelzet JA (2002) Procalcitonin as a prognostic marker in meningococcal disease. Intensive Care Med 28:1606-1612
22. Casado-Flores J, Blanco-Quiros A, Asensio J, Arranz E, Garrote JA, Nieto M (2003) Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Pediatr Crit Care Med 4:190-195
23. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA (1999) Diagnostic markers of infection: comparison of procalcitonin with C-reactive protein and leukocyte count. Arch Dis Child 81:417-421
24. Leclerc F, Leteurtre S, Noizet O, Dorkenoo A, Sadik A, Cremer R, Fourier C (2002) Procalcitonin as a prognostic marker in children with meningococcal septic shock. Arch Dis Child 87:450
25. Karabocuoglu M, Kaya O (2000) Plasma procalcitonin levels correlated with the severity of systemic meningococcal disease in children. Crit Care Med 28(Suppl):A170
26. Marzouk O, Bestwick K, Thomson APJ, Sills JA, Hart CA (1993) Variation in serum C-reactive protein across the clinical spectrum of meningococcal disease. Acta Paediatr 82:729-733
27. Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R (1997) Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score. Clin Infect Dis 25:640-646
28. Brunkhorst FM, Heinz U, Forycki ZF (1998) Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 24:888-892
29. Nylen E, Muller B, Becker KL, Snider R (2004) The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clin Infect Dis 36:823-824
30. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600-607
31. Carrol ED, Newland P, Thomson APJ, Hart CA (2005) Prognostic value of procalcitonin in children with meningococcal sepsis. Crit Care Med 33:224-225
32. Hackett SJ, Guiver M, Marsh J, Sills JA, Thomson APJ, Kaczmarski EB, Hart CA (2002) Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child 86:44-46